SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027927
Filing Date
2017-12-05
Accepted
2017-12-05 09:17:23
Documents
1
Period of Report
2017-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3123
  Complete submission text file 0000899243-17-027927.txt   4805
Mailing Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878 301-398-0000
MedImmune Ventures, Inc. (Reporting) CIK: 0001291884 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 171238771

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1